TVT2017: Experimental transcatheter device yields consistent, positive outcomes for patients

An experimental transcatheter device by Canada-based Neovasc, used to treat mitral regurgitation, was shown to be effective in treating a patient with several severe heart conditions.

The Tiara, still an investigational device, was shown in a presentation by Shmuel Banai, MD, the director of interventional cardiology at the Tel Aviv Medical Center and Neovasc’s medical director, at this year’s Transcatheter Valve Therapies (TVT) conference.

The device was implanted in a 79-year-old man in Lugano, Switzerland, who had ischemic cardiomyopathy, poor left ventricular function and severe mitral valve regurgitation. Physicians used a 35mm Tiara device on the patient, and the procedure was completed in 30 minutes. Seven weeks after the procedure, the patient was at home recovering well.

"This case highlights two critical aspects of the Tiara,” said Neovasc CEO Alexei Marko in a statement. “One, it clearly demonstrates the Tiara's medical role in very damaged and sick heart that simply are not candidates for conventional surgery, a patient pool that is unfortunately already large and growing. Two, the audience witnessed the elegant simplicity of this implantation procedure. Combined, these two themes underscore the Tiara's potential for the medical community and patients suffering from mitral regurgitation."

The Tiara has only been used in 30 patients in experimental settings across North American and Europe. Outcomes for patients who have received the Tiara have remained positive, and the company is working to get it approved for use in countries around the world.

 

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup